Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy
CompletedPhase 1NCT01505101
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions have been shown reduce chronic pain symptoms, addictive processes, and substance use. The investigators hypothesize that relative to a support group control condition, participation in a novel mindfulness-oriented cognitive intervention, Mindfulness-Oriented Recovery Enhancement (MORE), will result in improved well-being and decreased pain, opioid craving, and opioid misuse behaviors among chronic pain patients receiving opioid therapy.
Study details
- Official title
- Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy: Exploration of Cognitive, Affective, and Physiological Mechanisms
- Conditions
- Chronic Pain
- Opioid Abuse, Unspecified Use
- Interventions
- Behavioral: Mindfulness-Oriented Recovery Enhancement
- Behavioral: Conventional Support Group (SG)
- Sponsor
- Florida State University
- Collaborators
- National Institute on Drug Abuse (NIDA); Fahs Beck Fund for Research and Experimentation
- Start date
- 2011-10
- Primary completion
- 2013-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic pain diagnosis (ICD-9 diagnoses 338.xx) * treatment with prescription opioids for \> 3 months Exclusion Criteria: * prior mindfulness training * persons who are experiencing acute opioid withdrawal * suicidal ideation * psychosis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01505101